Cara Therapeutics (NASDAQ:CARA – Get Free Report) had its price target lowered by equities research analysts at Piper Sandler from $13.00 to $12.00 in a research note issued to investors on Tuesday, FlyOnTheWall reports. Piper Sandler’s price target would indicate a potential upside of 313.79% from the company’s previous close. A number of other research […]
Cara Therapeutics Reports Second Quarter 2023 Financial Results itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
Cara Therapeutics, Inc. (NASDAQ:CARA – Get Free Report) CEO Christopher Posner sold 4,307 shares of the stock in a transaction on Thursday, August 3rd. The shares were sold at an average price of $3.07, for a total value of $13,222.49. Following the completion of the sale, the chief executive officer now directly owns 168,207 shares […]
Cara Therapeutics (CARA) Appoints Helen M Boudreau to its Board streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.